Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Literature DB >> 11527792

Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

V G Hemming¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2001 PMID： 11527792 PMCID： PMC96160 DOI： 10.1128/CDLI.8.5.859-863.2001

Source DB: PubMed Journal: Clin Diagn Lab Immunol ISSN： 1071-412X

× No keyword cloud information.

49 in total

Review 1. Antibodies and resistance to natural HIV infection.

Authors: G J Nabel; N J Sullivan
Journal: N Engl J Med Date: 2000-10-26 Impact factor: 91.245

2. Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infection.

Authors: H R Hill
Journal: J Pediatr Date: 2000-11 Impact factor: 4.406

3. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XII. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PREVENTION AND ATTENUATION OF MEASLES.

Authors: C W Ordman; C G Jennings; C A Janeway
Journal: J Clin Invest Date: 1944-07 Impact factor: 14.808

4. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES.

Authors: J Stokes; E P Maris; S S Gellis
Journal: J Clin Invest Date: 1944-07 Impact factor: 14.808

5. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.

Authors: D R Snydman; B G Werner; B Heinze-Lacey; V P Berardi; N L Tilney; R L Kirkman; E L Milford; S I Cho; H L Bush; A S Levey
Journal: N Engl J Med Date: 1987-10-22 Impact factor: 91.245

6. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.

Authors: P J Mease; H D Ochs; R J Wedgwood
Journal: N Engl J Med Date: 1981-05-21 Impact factor: 91.245

Review 7. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.

Authors: A Ohlsson; J B Lacy
Journal: Cochrane Database Syst Rev Date: 2000

8. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.

Authors: K Sandberg; A Fasth; A Berger; M Eibl; K Isacson; A Lischka; A Pollak; I Tessin; K Thiringer
Journal: J Pediatr Date: 2000-11 Impact factor: 4.406

9. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors: V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal: J Clin Invest Date: 1976-12 Impact factor: 14.808

10. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

Authors: A A Fanaroff; S B Korones; L L Wright; E C Wright; R L Poland; C B Bauer; J E Tyson; J B Philips; W Edwards; J F Lucey
Journal: N Engl J Med Date: 1994-04-21 Impact factor: 91.245

17 in total

Review 1. Convalescent plasma: new evidence for an old therapeutic tool?

Authors: Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Liviana Catalano; Giancarlo M Liumbruno; Giuliano Grazzini
Journal: Blood Transfus Date: 2015-11-06 Impact factor: 3.443

2. The Effect of Container Surface Passivation on Aggregation of Intravenous Immunoglobulin Induced by Mechanical Shock.

Authors: Sanli Movafaghi; Hao Wu; Irene M Francino Urdániz; David S Bull; Mary D Kelly; Theodore W Randolph; Andrew P Goodwin
Journal: Biotechnol J Date: 2020-06-08 Impact factor: 4.677

3. The Effectiveness of Different Doses of Intravenous Immunoglobulin on Severe Hand, Foot and Mouth Disease: A Meta-Analysis.

Authors: Wei Jiao; Si-Ran Tan; Yan-Feng Huang; Li-Hong Mu; Yang Yang; Yan Wang; Xue-E Wu
Journal: Med Princ Pract Date: 2019-01-15 Impact factor: 1.927

4. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.

Authors: John M Dye; Hua Wu; Jay W Hooper; Surender Khurana; Ana I Kuehne; Elizabeth M Coyle; Ramon A Ortiz; Sandra Fuentes; Andrew S Herbert; Hana Golding; Russell A Bakken; Jennifer M Brannan; Steve A Kwilas; Eddie J Sullivan; Thomas C Luke; Gale Smith; Gregory Glenn; Wenfang Li; Ling Ye; Chinglai Yang; Richard W Compans; Ralph A Tripp; Jin-An Jiao
Journal: Sci Rep Date: 2016-04-25 Impact factor: 4.379

5. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.

Authors: Steven Rockman; Sue Lowther; Sarina Camuglia; Kirsten Vandenberg; Shirley Taylor; Lou Fabri; Sylvia Miescher; Martin Pearse; Deborah Middleton; Stephen J Kent; Darryl Maher
Journal: EBioMedicine Date: 2017-04-06 Impact factor: 8.143

6. The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease: a nationwide population-based matched cohort study.

Authors: Wei-Te Lei; Chien-Yu Lin; Yu-Hsuan Kao; Cheng-Hung Lee; Chao-Hsu Lin; Shyh-Dar Shyur; Kuender-Der Yang; Jian-Han Chen
Journal: PeerJ Date: 2018-03-22 Impact factor: 2.984

Review 10. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0).

Authors: Taisheng Li
Journal: Emerg Microbes Infect Date: 2020-03-14 Impact factor: 7.163